Accessibility Menu
NeuroOne Medical Technologies Stock Quote

NeuroOne Medical Technologies (NASDAQ: NMTC)

$0.77
(-6.0%)
-0.05
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$0.77
Daily Change
(-6.0%) $0.05
Day's Range
$0.76 - $0.83
Previous Close
$0.77
Open
$0.81
Beta
0.95
Volume
406,669
Average Volume
399,921
Market Cap
38.5M
Market Cap / Employee
$0.77M
52wk Range
$0.4 - $1.39
Revenue
-
Gross Margin
0.70%
Dividend Yield
N/A
EPS
-$0.16
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

NeuroOne Medical Technologies Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
NMTC-16.27%-76.87%-25.38%-94%
S&P+15.06%+95.03%+14.29%+172%

NeuroOne Medical Technologies Company Info

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$1.70M105.4%
Gross Profit$0.91M224.6%
Gross Margin53.94%19.8%
Market Cap$33.79M51.7%
Market Cap / Employee$1.99M0.0%
Employees170.0%
Net Income-$1.50M45.8%
EBITDA-$1.82M33.4%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$8.04M396.3%
Accounts Receivable$0.00M-100.0%
Inventory1.95.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.18M-16.5%
Short Term Debt$0.12M50.1%

Ratios

Q2 2025YOY Change
Return On Assets-67.85%159.0%
Return On Invested Capital-443.51%-352.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$1.51M36.6%
Operating Free Cash Flow-$1.46M38.0%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book9.1530.978.9318.91246.15%
Price to Sales8.582.913.023.42-38.62%
Price to Tangible Book Value9.3833.729.1319.90256.86%
Enterprise Value to EBITDA-10.3313.91-9.73-13.8684.15%
Return on Equity-348.4%-195.5%-265.2%-95.4%-72.68%
Total Debt$0.26M$0.34M$0.31M$0.30M1.94%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.